GO:0038064 collagen receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0038064 collagen receptor activity is a molecular function defined as combining with a collagen and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
• The term is synonymous with transmembrane collagen receptor activity and is distinct from collagen binding alone because it requires signal transduction across the membrane.
• Major collagen receptor families include integrins, discoidin domain receptors (DDR1 and DDR2), GPVI, and other immunoglobulin-like receptors such as LAIR-1 and OSCAR.
• Collagen receptor signaling controls platelet activation, cell adhesion, migration, proliferation, differentiation, and extracellular matrix remodeling.
• Dysregulated collagen receptor activity contributes to cancer progression, fibrosis, arthritis, and thrombotic disorders.
• CRISPR knockout, point-mutation knock-in, and overexpression models are essential for dissecting the causal roles of individual collagen receptors.
Description
Collagen is the most abundant protein in the extracellular matrix and acts not only as a structural scaffold but also as a signaling ligand. Cells sense collagen through dedicated transmembrane receptors that convert extracellular collagen engagement into intracellular signals, a function captured by the Gene Ontology term GO:0038064, collagen receptor activity. This term describes the molecular activity of combining with a collagen and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. Collagen receptor activity is central to hemostasis, tissue development, immune regulation, and cancer progression, making it a high-priority target for mechanistic and translational research [1,8]. Understanding which receptors mediate specific collagen responses, and how their signaling is wired, requires precise genetic models and functional assays. This article provides a research-grade overview of GO:0038064, covering its definition, core mechanisms, key genes, disease links, and the CRISPR-based methods used to study it.
collagen receptor activity At A Glance
| GO ID | GO:0038064 |
|---|---|
| GO term | collagen receptor activity |
| Ontology | molecular_function |
| Synonym | transmembrane collagen receptor activity |
| Definition | Combining with a collagen and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. |
| Major function | Transmembrane sensing of collagen to initiate intracellular signaling and cellular responses. |
| Representative receptors | Integrins, DDR1, DDR2, GPVI, LAIR-1, OSCAR |
| Associated processes | Platelet activation, cell adhesion, migration, proliferation, differentiation, matrix remodeling |
| Disease relevance | Cancer, fibrosis, arthritis, thrombosis, and inflammatory disorders |
What Is GO:0038064?
GO:0038064 collagen receptor activity is a molecular function in which a protein binds to collagen and, upon binding, transmits a signal across the plasma membrane to initiate a change in cell behavior. The definition emphasizes two inseparable features: collagen recognition and transmembrane signal transduction. This distinguishes collagen receptor activity from passive collagen binding, because the receptor must actively convert ligand engagement into an intracellular signal. The synonym transmembrane collagen receptor activity highlights the requirement for membrane spanning and signal relay. Receptors with this activity include integrin heterodimers, discoidin domain receptors, and immunoglobulin-like receptors such as GPVI [7,8].
Why Is collagen receptor activity Important in Cell Biology?
Collagen receptor activity is important because it links the mechanical and biochemical state of the extracellular matrix to cell fate decisions. In hemostasis, platelet collagen receptors such as GPVI and integrin alpha2beta1 are required for platelet activation and thrombus formation [3,8]. In development and tissue homeostasis, collagen receptors regulate adhesion, migration, proliferation, and differentiation, and their dysregulation contributes to cancer, fibrosis, and arthritis [1,6]. Because collagen is abundant and ubiquitous, the specificity of downstream responses depends on which receptors are expressed and how their signaling is regulated. This makes collagen receptor activity a central node in both normal physiology and disease, and a compelling target for genetic and pharmacological interrogation.
• Controls platelet activation and thrombus formation through GPVI and integrin alpha2beta1 [3,8].
• Regulates cell adhesion, migration, and invasion on collagen-rich matrices.
• DDR1 and DDR2 transmit collagen signals that influence proliferation, differentiation, and matrix remodeling [1,4].
• Integrin alpha11beta1 contributes to joint destruction in inflammatory arthritis.
• Collagen receptor signaling in cancer cells and fibroblasts promotes metastatic niche formation.
• DDR1 kinase activity regulates collagen IV synthesis, linking receptor signaling to matrix feedback.
• Provides mechanistic insight into fibrosis, where excessive collagen deposition and receptor activation reinforce disease.
• Offers targets for antiplatelet, antifibrotic, and anticancer therapeutic strategies [1,8].
• Requires precise genetic models to separate ligand binding from signal transduction.
• Connects extracellular matrix biology to intracellular kinase and cytoskeletal networks.
What Happens During collagen receptor activity?
Collagen recognition and receptor engagement
In simple terms: The receptor first grabs onto collagen outside the cell.
Collagen receptor activity begins when a transmembrane receptor binds collagen in the extracellular matrix. Different receptors recognize distinct collagen motifs and conformations. Integrins such as alpha1beta1, alpha2beta1, alpha10beta1, and alpha11beta1 bind collagen through their inserted I domain, while discoidin domain receptors DDR1 and DDR2 bind collagen through their discoidin domains. GPVI binds collagen through immunoglobulin-like domains and is a key platelet collagen receptor. This recognition step is the prerequisite for all downstream signaling.
Transmembrane signal transmission
In simple terms: The receptor changes shape and passes the message across the membrane.
Upon collagen binding, the receptor undergoes conformational changes that propagate across the plasma membrane. For integrins, ligand binding triggers talin and kindlin recruitment, integrin activation, and clustering, which in turn activates focal adhesion kinase and Src family kinases. For DDR1 and DDR2, collagen binding induces receptor dimerization and autophosphorylation of the kinase domain, initiating downstream signaling [1,4]. This step defines the transmembrane signaling character of GO:0038064.
Intracellular signaling cascades
In simple terms: Inside the cell, the receptor switches on a chain of signaling proteins.
Activated collagen receptors nucleate signaling complexes. Integrin engagement recruits focal adhesion kinase, Src, paxillin, and cytoskeletal adaptors, leading to actin reorganization and changes in adhesion dynamics. DDR1 signaling involves phosphorylation of downstream effectors such as Shc, STAT, and NF-kB, and DDR1 kinase activity is required for regulating collagen IV synthesis. GPVI signals through the Fc receptor gamma chain and Syk, leading to platelet activation. These cascades convert collagen recognition into changes in gene expression, cytoskeletal organization, and cell behavior.
Cellular responses and feedback
In simple terms: The cell responds by moving, growing, or changing what it makes.
Collagen receptor signaling produces context-dependent outcomes including platelet aggregation, cell spreading, migration, proliferation, differentiation, and matrix remodeling [3,7]. In platelets, collagen receptor engagement under flow conditions differentially regulates integrin activity, tuning thrombus formation. In cancer, collagen-DDR1 signaling promotes tumor progression and matrix remodeling. In arthritis, integrin alpha11beta1 contributes to joint destruction. Feedback loops, such as DDR1-dependent regulation of collagen IV synthesis, can further modify the matrix environment.
Key Genes Involved in GO:0038064 collagen receptor activity
The following genes encode receptors or receptor subunits that carry collagen receptor activity, together with key signaling components that mediate their downstream effects.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ITGA1 | Integrin alpha1 subunit; collagen-binding integrin alpha1beta1 | Mediates collagen-dependent adhesion and signaling in fibroblasts and immune cells |
| ITGA2 | Integrin alpha2 subunit; collagen-binding integrin alpha2beta1 | Platelet collagen receptor and adhesion receptor in many cell types [3,7] |
| ITGA10 | Integrin alpha10 subunit; collagen-binding integrin alpha10beta1 | Cartilage collagen receptor involved in chondrocyte function |
| ITGA11 | Integrin alpha11 subunit; collagen-binding integrin alpha11beta1 | Promotes fibroblast-mediated metastasis and joint destruction [5,6] |
| ITGB1 | Integrin beta1 subunit; common partner for collagen-binding integrins | Essential for integrin heterodimer formation and signaling |
| DDR1 | Discoidin domain receptor 1; collagen-activated tyrosine kinase | Regulates collagen IV synthesis and cancer progression [1,4] |
| DDR2 | Discoidin domain receptor 2; collagen-activated tyrosine kinase | Mediates collagen signaling in fibroblasts and cartilage |
| GP6 | Glycoprotein VI; platelet collagen receptor | Central platelet collagen receptor for activation and thrombus formation |
| FCER1G | Fc receptor gamma chain; GPVI signaling adaptor | Transmits GPVI signals via ITAM and Syk |
| SYK | Spleen tyrosine kinase; downstream of GPVI | Key kinase in platelet collagen signaling |
| PTK2 | Focal adhesion kinase; integrin signaling effector | Mediates integrin-dependent adhesion signaling |
| SRC | Src family kinase; integrin and DDR signaling | Phosphorylates downstream targets upon collagen receptor activation |
| LAIR1 | Leukocyte-associated immunoglobulin-like receptor 1; collagen receptor | Inhibitory collagen receptor on immune cells |
| OSCAR | Osteoclast-associated immunoglobulin-like receptor; collagen receptor | Regulates osteoclast biology via collagen recognition |
| COL1A1 | Type I collagen alpha1 chain; ligand for collagen receptors | Major extracellular ligand whose availability shapes receptor signaling |
| COL4A1 | Type IV collagen alpha1 chain; ligand and DDR1-regulated product | Links DDR1 activity to basement membrane synthesis |
| TALIN1 | Integrin-activating adaptor | Required for integrin activation upon collagen engagement |
| KINDlin | Integrin-activating adaptor | Facilitates integrin clustering and signaling |
How Is collagen receptor activity Regulated?
Collagen receptor activity is regulated at multiple levels. Receptor expression levels and splicing determine which collagen receptors a cell uses. Integrin activity is controlled by inside-out signaling through talin and kindlin, which switch integrins from low- to high-affinity states. DDR1 and DDR2 are regulated by ligand-induced dimerization, autophosphorylation, and kinase activity, and DDR1 kinase activity is required for regulating collagen IV synthesis. In platelets, collagen receptor engagement under flow conditions differentially regulates integrin activity, showing that biomechanical context tunes signaling output. Extracellular matrix composition, collagen crosslinking, and proteolytic remodeling also modulate receptor engagement. These layers of regulation ensure that collagen receptor signaling is context-specific and reversible.
collagen receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DDR1 | Cancer progression and collagen IV synthesis | DDR1 knockout and kinase-dead knock-in cancer cell lines [1,4] |
| ITGA11 | Lung metastasis and arthritic joint destruction | ITGA11 knockout fibroblasts and hTNFtg arthritis models [5,6] |
| GP6 | Thrombosis and platelet activation | GP6 knockout platelets and thrombosis models |
| ITGA2 | Platelet adhesion and thrombus formation under flow | ITGA2 knockout platelets in microfluidic flow assays |
| DDR2 | Fibrosis and cartilage biology | DDR2 knockout fibroblasts and chondrocytes |
Cancer progression and metastasis
Collagen receptor signaling is frequently dysregulated in cancer. DDR1 signaling in tumor cells and the microenvironment promotes proliferation, invasion, and matrix remodeling, and multifaceted collagen-DDR1 signaling is recognized as a driver of cancer progression. Integrin alpha11beta1 on fibroblasts is activated by osteosarcoma-secreted CXCL14 to form a lung metastatic niche, demonstrating how collagen receptor activity in stromal cells supports metastasis. Targeting collagen receptor pathways is therefore an active area of anticancer research.
Inflammatory arthritis and joint destruction
Collagen-binding integrin alpha11beta1 contributes to joint destruction in arthritic hTNFtg mice, linking collagen receptor activity to cartilage and bone erosion. DDR1 and DDR2 also respond to collagen in inflamed joints and can amplify fibrotic and inflammatory responses. These findings position collagen receptors as potential therapeutic targets in rheumatoid arthritis and related disorders.
Thrombosis and hemostasis
Platelet collagen receptors are central to thrombus formation. GPVI is a key platelet collagen receptor, and the question of whether GPVI is the central receptor has driven extensive research. Integrin alpha2beta1 also contributes to platelet adhesion and activation on collagen, and differential integrin activity mediated by platelet collagen receptor engagement under flow conditions shapes thrombus growth. Dysregulated platelet collagen receptor activity can contribute to thrombotic disease.
Fibrosis and matrix remodeling
Collagen receptor activity is both a sensor and a driver of fibrosis. DDR1 kinase activity regulates collagen IV synthesis, creating a feedback loop between receptor signaling and matrix production. In fibrotic tissues, excessive collagen deposition increases receptor engagement, which in turn promotes fibroblast activation and further matrix deposition. This positive feedback makes collagen receptors attractive targets for antifibrotic strategies.
From collagen receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a collagen receptor impair cell adhesion or signaling? | CRISPR knockout cell line or primary cells |
| Is kinase activity required for downstream signaling? | Point-mutation knock-in of kinase-dead allele |
| Does a disease-associated variant alter collagen receptor function? | Point-mutation knock-in of the variant |
| Where and when is the receptor expressed? | Tagged knock-in with fluorescent or epitope tag |
| Does overexpression mimic a disease phenotype? | Overexpression cell line or transgenic model |
| Which genes cooperate with the receptor in disease? | CRISPR library screening and bioinformatics |
How to Study the collagen receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss-of-function phenotype | Test whether a collagen receptor is required for adhesion or signaling |
| Point-mutation knock-in | Effect of specific amino acid changes | Dissect kinase activity or ligand-binding residues |
| Overexpression | Gain-of-function phenotype | Model receptor-driven disease states |
| Phosphoproteomics | Signaling network changes | Map downstream pathways of DDR1 or integrins |
| Live-cell imaging | Receptor dynamics and adhesion | Visualize collagen receptor clustering and turnover |
| Platelet aggregation assay | Platelet activation | Study GPVI and integrin alpha2beta1 function [3,8] |
| CRISPR library screening | Genetic dependencies | Identify modifiers of collagen receptor signaling |
Genetic perturbation and phenotypic assays
CRISPR knockout, point-mutation knock-in, and overexpression models are used to test the causal role of collagen receptors. Adhesion, migration, proliferation, and platelet aggregation assays measure downstream phenotypes. These approaches are essential for linking GO:0038064 activity to specific cellular outcomes [3,7].
Biochemical signaling analysis
Phosphoproteomics, immunoblotting, and kinase assays measure receptor autophosphorylation and downstream signaling. DDR1 kinase activity can be assessed by phospho-DDR1 antibodies and by collagen IV synthesis readouts. Integrin activation states can be measured with conformation-specific antibodies.
Imaging and matrix interaction studies
Live-cell imaging, total internal reflection fluorescence microscopy, and traction force microscopy visualize receptor clustering, adhesion dynamics, and matrix remodeling. These methods reveal how collagen receptor activity is spatially and temporally organized.
Transcriptomics and CRISPR screening
RNA-seq and CRISPR library screening identify transcriptional programs and genetic dependencies downstream of collagen receptor activity. Bioinformatics integration of screening data with expression and pathway databases helps prioritize candidate genes for follow-up [1,5].
How CRISPR Can Be Used to Study GO:0038064 collagen receptor activity
Knockout
CRISPR knockout of collagen receptor genes such as DDR1, ITGA11, or GP6 eliminates receptor expression and allows researchers to test necessity in adhesion, migration, platelet activation, and disease models [4,5,8]. Knockout cell lines are foundational for validating GO:0038064-related phenotypes.
Point Mutation
Point-mutation knock-in can introduce kinase-dead alleles, ligand-binding mutations, or disease-associated variants. For example, kinase-dead DDR1 knock-in can separate collagen binding from kinase signaling, directly testing the requirement for DDR1 kinase activity in collagen IV regulation.
Knock-in
Tagged knock-in of endogenous collagen receptor loci enables visualization and purification of receptors under native regulation. This is valuable for studying receptor localization, trafficking, and interaction partners without overexpression artifacts.
Overexpression
Overexpression models can mimic gain-of-function states observed in cancer and fibrosis. Overexpressing DDR1 or integrin alpha11beta1 in appropriate cell types can reveal sufficiency for proliferation, invasion, or matrix remodeling [1,5].
How EDITGENE Supports collagen receptor activity Research
Researchers studying collagen receptor activity-related genes often need to determine whether a candidate gene is causally involved in collagen sensing, signaling, or disease phenotypes. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell models that answer these questions.
Contact EDITGENE today to design your custom CRISPR model for collagen receptor activity research.
Frequently Asked Questions About collagen receptor activity
What is collagen receptor activity?
Collagen receptor activity (GO:0038064) is a molecular function in which a receptor binds collagen and transmits a signal across the membrane to initiate a change in cell activity.
What genes are involved in collagen receptor activity?
Key genes include ITGA1, ITGA2, ITGA10, ITGA11, ITGB1, DDR1, DDR2, GP6, FCER1G, SYK, LAIR1, and OSCAR [1,3,7,8].
What is the difference between collagen binding and collagen receptor activity?
Collagen binding is ligand recognition alone, whereas collagen receptor activity requires transmembrane signal transduction to change cell behavior.
Which receptors have collagen receptor activity?
Integrins, discoidin domain receptors DDR1 and DDR2, GPVI, LAIR-1, and OSCAR are major collagen receptors [7,8].
How is collagen receptor activity studied?
Common methods include CRISPR knockout, point-mutation knock-in, phosphoproteomics, live-cell imaging, and platelet aggregation assays [3,4,7].
What diseases involve collagen receptor activity?
Cancer, fibrosis, inflammatory arthritis, and thrombosis are linked to dysregulated collagen receptor signaling [1,5,6,8].
Is DDR1 a collagen receptor?
Yes, DDR1 is a collagen-activated receptor tyrosine kinase that signals upon collagen binding and regulates collagen IV synthesis [1,4].
What is the role of GPVI in collagen receptor activity?
GPVI is a platelet collagen receptor that signals through FCER1G and SYK to activate platelets and promote thrombus formation.
Can CRISPR knockout help study collagen receptor activity?
Yes, CRISPR knockout of receptor genes such as DDR1, ITGA11, or GP6 tests whether the receptor is required for specific collagen responses [4,5,8].
What is the GO ID for collagen receptor activity?
The GO ID is GO:0038064, with synonym transmembrane collagen receptor activity.
Conclusion
GO:0038064 collagen receptor activity defines the essential molecular function by which cells sense collagen and convert that recognition into intracellular signals. From platelet activation to cancer progression and fibrosis, collagen receptors such as integrins, DDR1, DDR2, and GPVI shape physiology and disease [1,3,7,8]. Precise genetic models, including CRISPR knockout, point-mutation knock-in, and overexpression, are critical for dissecting receptor-specific mechanisms. Continued research into collagen receptor activity will inform new therapeutic strategies for thrombosis, cancer, arthritis, and fibrotic disease.
References
- 1. Su H et al.. 2024. Multifaceted collagen-DDR1 signaling in cancer.. Trends Cell Biol 34(5):406-415 PMID: 37709651
- 3. Pugh N et al.. 2017. Differential integrin activity mediated by platelet collagen receptor engagement under flow conditions.. Thromb Haemost 117(8):1588-1600 PMID: 28536721
- 4. Borza CM et al.. 2017. Discoidin domain receptor 1 kinase activity is required for regulating collagen IV synthesis.. Matrix Biol 57-58:258-271 PMID: 27915093
- 5. Xu Y et al.. 2024. Osteosarcoma Cells Secrete CXCL14 That Activates Integrin α11β1 on Fibroblasts to Form a Lung Metastatic Niche.. Cancer Res 84(7):994-1012 PMID: 38295227
- 6. De Giuseppe A et al.. 2025. Collagen-binding integrin α11β1 contributes to joint destruction in arthritic hTNFtg mice.. Ann Rheum Dis 84(10):1649-1659 PMID: 40816940
- 7. Leitinger B. 2011. Transmembrane collagen receptors.. Annu Rev Cell Dev Biol 27:265-90 PMID: 21568710
- 8. Nieswandt B et al.. 2003. Platelet-collagen interaction: is GPVI the central receptor?. Blood 102(2):449-61 PMID: 12649139
